Skip to main content
Top
Published in: Supportive Care in Cancer 9/2008

01-09-2008 | Original Article

Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an International survey

Authors: Sultan Kav, Judi Johnson, Cynthia Rittenberg, Paz Fernadez-Ortega, Tarja Suominen, Pia Riis Olsen, Elisabeth Patiraki, Davina Porock, Annette Dahler, Jolanta Toliusiene, Dusanka Tadic, Pongpak Pittayapan, Vijay Roy, Qi Wang, Meric Colak, Hanan Saca-Hazboun, David Makumi, Ilana Kadmon, Sarah Ben Ami, Elsie Anderson, Rebecca Clark-Snow

Published in: Supportive Care in Cancer | Issue 9/2008

Login to get access

Abstract

Purpose

The aim of this study was to explore the nursing role in education and follow-up of patients who were taking oral chemotherapy (CT) and to identify the worldwide gap in patient education about oral CT.

Materials and methods

Multinational Association of Supportive Care in Cancer members were invited to participate in a survey on oral CT. Nurse coordinators collected data via a 16-item questionnaire. Respondents totaled 1115 oncology nurses from 15 countries.

Results

Findings showed that about half of subjects work in outpatient/ambulatory clinics and had given at least two or more oral CT drugs. Although 52% had some type of guidelines/protocols, 47% reported not having received any education about oral CT drugs. While 64% report being involved in patient education, 58% of subjects indicated lack of patient education materials that are specific for oral CT agents. Only 27% stated that they gave all necessary information such as when and how to take the drugs, drug safety and storage, side effects, and symptom management. Reasons for not being involved in oral CT education and follow-up included beliefs that the physician plans the oral CT and gives patients necessary instructions (34%), that nurses only see patients who receive intravenous chemotherapy (16%), that nurses have lack of knowledge about oral agents (15%), and belief that physicians are responsible for patient follow-up. The nurses suggested better education and follow-up of patients to include the written patient education materials (33%) and professional education for nurses (30%).

Conclusions

Findings revealed the need for professional education for nurses to ensure comprehensive, consistent patient education and development of written materials for patients receiving oral CT treatment.
Literature
1.
go back to reference Aisner J (2007) Overview of the changing paradigm in cancer treatment: oral chemotherapy. Am J Health-Syst Pharm 64(9 Suppl 5):S4–S7PubMedCrossRef Aisner J (2007) Overview of the changing paradigm in cancer treatment: oral chemotherapy. Am J Health-Syst Pharm 64(9 Suppl 5):S4–S7PubMedCrossRef
2.
go back to reference Atkins L, Fallowfield L (2006) Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer 42(14):2271–2276PubMedCrossRef Atkins L, Fallowfield L (2006) Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer 42(14):2271–2276PubMedCrossRef
3.
go back to reference Bartel SB (2007) Safe practices and financial considerations in using oral chemotherapeutic agents. Am J Health Syst Pharm 64(9 Suppl 5):S8–S14PubMedCrossRef Bartel SB (2007) Safe practices and financial considerations in using oral chemotherapeutic agents. Am J Health Syst Pharm 64(9 Suppl 5):S8–S14PubMedCrossRef
4.
go back to reference Bedell CH (2003) A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):5–9PubMedCrossRef Bedell CH (2003) A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs 7(Suppl 6):5–9PubMedCrossRef
5.
go back to reference Catania C, Didier F, Leon ME, Sbanotto A, Mariani L, Nolè F, Leida E, Rocca A, De Pas T, Goldhirsch A (2005) Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer. Breast Cancer Res Treat 92(3):265–272PubMedCrossRef Catania C, Didier F, Leon ME, Sbanotto A, Mariani L, Nolè F, Leida E, Rocca A, De Pas T, Goldhirsch A (2005) Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer. Breast Cancer Res Treat 92(3):265–272PubMedCrossRef
6.
7.
go back to reference Fallowfield L, Atkins L, Catt S, Cox A, Coxon C, Langridge C, Morris R, Price M (2006) Patients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Ann Oncol 17(2):205PubMedCrossRef Fallowfield L, Atkins L, Catt S, Cox A, Coxon C, Langridge C, Morris R, Price M (2006) Patients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Ann Oncol 17(2):205PubMedCrossRef
8.
go back to reference Goodin S (2007) Advancing the safe and appropriate use of oral chemotherapy agents. Am J Health Syst Pharm 64(9 Suppl 5):S3CrossRef Goodin S (2007) Advancing the safe and appropriate use of oral chemotherapy agents. Am J Health Syst Pharm 64(9 Suppl 5):S3CrossRef
9.
go back to reference Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6):21–24PubMedCrossRef Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6):21–24PubMedCrossRef
10.
go back to reference Hollywood E, Semple D (2001) Nursing strategies for patients on oral chemotherapy. Oncology 15(Suppl 2):37–40PubMed Hollywood E, Semple D (2001) Nursing strategies for patients on oral chemotherapy. Oncology 15(Suppl 2):37–40PubMed
11.
go back to reference Kav S, Bostanci H (2006) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey. Support Care Cancer 14(12):1252–1257PubMedCrossRef Kav S, Bostanci H (2006) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey. Support Care Cancer 14(12):1252–1257PubMedCrossRef
12.
go back to reference Kelly A, Agius CR (2006) Improving adherence to endocrine therapies: the role of advanced practice nurses. Oncology (Nurse Edition) 20(10 Suppl 7):50–54 Kelly A, Agius CR (2006) Improving adherence to endocrine therapies: the role of advanced practice nurses. Oncology (Nurse Edition) 20(10 Suppl 7):50–54
13.
go back to reference Macintosh PW, Pond GR, Pond BJ, Leung V, Siu LL (2007) A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes. Eur J Cancer Care 16(4):380–386CrossRef Macintosh PW, Pond GR, Pond BJ, Leung V, Siu LL (2007) A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes. Eur J Cancer Care 16(4):380–386CrossRef
14.
go back to reference MacLeod A, Branch A, Cassidy J, McDonald A, Mohammed N, MacDonald L (2007) A nurse-/pharmacy-led capecitabine clinic for colorectal cancer: results of a prospective audit and retrospective survey of patient experiences. Eur J Oncol Nurs 11:247–254PubMedCrossRef MacLeod A, Branch A, Cassidy J, McDonald A, Mohammed N, MacDonald L (2007) A nurse-/pharmacy-led capecitabine clinic for colorectal cancer: results of a prospective audit and retrospective survey of patient experiences. Eur J Oncol Nurs 11:247–254PubMedCrossRef
15.
go back to reference Malbasa T, Kodish E, Santacroce SJ (2007) Adolescent adherence to oral therapy for leukemia: a focus group study. J Pediatr Oncol Nurs 24(3):139–151PubMedCrossRef Malbasa T, Kodish E, Santacroce SJ (2007) Adolescent adherence to oral therapy for leukemia: a focus group study. J Pediatr Oncol Nurs 24(3):139–151PubMedCrossRef
16.
go back to reference McDonald H, Garg A, Haynes B (2002) Interventions to enhance patient adherence to medication prescriptions. J Am Med Assoc 288(22):2868–2879CrossRef McDonald H, Garg A, Haynes B (2002) Interventions to enhance patient adherence to medication prescriptions. J Am Med Assoc 288(22):2868–2879CrossRef
17.
go back to reference Moore S (2007) Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 30(2):112–122PubMedCrossRef Moore S (2007) Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 30(2):112–122PubMedCrossRef
19.
go back to reference Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652–661PubMed Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652–661PubMed
20.
go back to reference Taylor JA, Winter L, Geyer LJ, Hawkins DS (2006) Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. Cancer 107(6):1400–1406PubMedCrossRef Taylor JA, Winter L, Geyer LJ, Hawkins DS (2006) Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. Cancer 107(6):1400–1406PubMedCrossRef
21.
go back to reference Twelves C, Gollins S, Grieve R, Samuel L (2006) A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer. Ann Oncol 17(2):239–245PubMedCrossRef Twelves C, Gollins S, Grieve R, Samuel L (2006) A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer. Ann Oncol 17(2):239–245PubMedCrossRef
22.
go back to reference Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN, Connor M (2007) Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ 334:407–411PubMedCrossRef Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN, Connor M (2007) Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ 334:407–411PubMedCrossRef
23.
go back to reference Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26(5):331–342PubMedCrossRef Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26(5):331–342PubMedCrossRef
24.
go back to reference Viele CS (2007) Managing oral chemotherapy: the healthcare practitioner’s role. Am J Health Syst Pharm 64(9 Suppl 5):S25–S32PubMedCrossRef Viele CS (2007) Managing oral chemotherapy: the healthcare practitioner’s role. Am J Health Syst Pharm 64(9 Suppl 5):S25–S32PubMedCrossRef
25.
go back to reference Vlasnik JJ, Aliotta SL, Delor B (2005) Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager 16:47–50 (March/April)PubMedCrossRef Vlasnik JJ, Aliotta SL, Delor B (2005) Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager 16:47–50 (March/April)PubMedCrossRef
Metadata
Title
Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an International survey
Authors
Sultan Kav
Judi Johnson
Cynthia Rittenberg
Paz Fernadez-Ortega
Tarja Suominen
Pia Riis Olsen
Elisabeth Patiraki
Davina Porock
Annette Dahler
Jolanta Toliusiene
Dusanka Tadic
Pongpak Pittayapan
Vijay Roy
Qi Wang
Meric Colak
Hanan Saca-Hazboun
David Makumi
Ilana Kadmon
Sarah Ben Ami
Elsie Anderson
Rebecca Clark-Snow
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2008
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0377-x

Other articles of this Issue 9/2008

Supportive Care in Cancer 9/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine